Psychiatr. pro Praxi, 2003; 3: 144-145

Léčba tikových poruch

prof. MUDr. Ivana Drtílková CSc
Psychiatrická klinika LF MU a FN Brno

Published: December 31, 2003  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Drtílková I. Léčba tikových poruch. Psychiatr. praxi. 2003;4(3):144-145.

Tikové poruchy začínají obvykle v dětství a přecházejí do dospělosti. Na rozdíl od Přechodné tikové poruchy, která v dětství spontánně vymizí, Chronická motorická nebo vokální porucha a Kombinovaná vokální a mnohočetná tiková porucha (Tourettův syndrom) obvykle přecházejí do dospělosti, avšak asi u 50 % postižených od preadolescentního období postupně dochází k ústupu tiků. Tikové poruchy zpravidla vyžadují dlouhodobou farmakologickou léčbu, která může trvat desítky let. Studie zaměřené na zkoumání efektu psychofarmak u tikových poruch nerozlišují mezi chronickou tikovou poruchou a Tourettovým syndromem.

Z komorbidních poruch je nejčastěji přítomna psychopatologie z oblasti obsedantně kompulzivní poruchy (OCD) a hyperkinetické poruchy (ADHD).

Download citation

References

  1. Bruggeman R, van der Linden C. Risperidone versus pimozide in Tourette disorder: a comparative double-blind parallel group study. J. Clin. Psychiatry 2001; 62 (1): 50-56. Go to original source... Go to PubMed...
  2. Drtílková I, Balaštíková B. Tiaprid, clonazepam a clonidin u dětí s tikovou a komorbidní hyperkinetickou poruchou. ČS Psychiatrie 1997; suppl 3: 54-78.
  3. Gaffney G, Perry P, Lund B. Risperidone versus clonidine in the treatment of children and adolescents with Tourettes syndrome. J. Am. Acad. Child Adol. Psychiatry 2002; 41 (3): 330-336. Go to original source... Go to PubMed...
  4. Goetz CG. Clonidine and clonazepam in Tourette syndrome1992; Adv Neurol 58: 245-251.
  5. Lomboroso PJ, Scahill L. Risperidone treatment of children and adolescents with chronic tic disorders. J Am Acas Child Adol Psychiatry 1996; 35 (7): 839-840.
  6. Onofrj M, Paci C. Olanzapine in severe Gilles de la Tourette syndrome: a 52 week double-blind cross-over study vs.low-dose pimozide. J Neurol 2000; 247(6): 443-. Go to original source... Go to PubMed...
  7. Robertson MM, Stern JS. Gilles de la Tourette syndrome: symptomatic treatment based on evidence.Eur Child Adolesc Psychiatry 2000; 9: 160-175. Go to original source... Go to PubMed...
  8. Salle FR, Kurlan MD. Ziprasidone treatment of children and adolescents with Tourettes syndrome: a pilot study. J. Am. Acad. Child Adol. Psychiatry 2000; 39(3): 292-298. Go to original source... Go to PubMed...
  9. Scahill L, Riddle MA. Fluoxetine has no marked effect on tic symptoms in patients with Tourettes syndrome: a double-blind placebo-controlled study. J Child Adol Psychopharmacology 1997; 7(2): 75-85. Go to original source... Go to PubMed...




Psychiatry for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.